71 related articles for article (PubMed ID: 6508478)
1. [Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients].
Liaño H; López-Lozano JJ; Ramírez A; Rabes C; Pascual ML
Arch Neurobiol (Madr); 1984; 47(3):143-50. PubMed ID: 6508478
[No Abstract] [Full Text] [Related]
2. [Bromocriptine in Parkinson's disease. Personal experience].
Chacón JR; Piqueras L; Pery JM
Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
[No Abstract] [Full Text] [Related]
3. [Treatment of Parkinson disease by bromocriptine in the black African].
Ndiaye IP; Jacquin-Cotton L; Martini L
Dakar Med; 1980; 25(2):131-5. PubMed ID: 7215100
[No Abstract] [Full Text] [Related]
4. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis.
Sampaio C; Coelho T; Castro-Caldas A; Bastos-Lima A; Levy A
J Neural Transm Suppl; 1995; 45():197-202. PubMed ID: 8748626
[TBL] [Abstract][Full Text] [Related]
5. [Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
Haas JA; Lakke JP
Ned Tijdschr Geneeskd; 1982 Apr; 126(16):701-5. PubMed ID: 7088202
[No Abstract] [Full Text] [Related]
6. A comparative study of bromocriptine and levodopa in Parkinson's disease.
Duvoisin RC; Mendoza MM; Yahr MD
Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
[No Abstract] [Full Text] [Related]
7. [Parlodel: a new therapeutic possibility in the management of Parkinson disease].
Glaub T; Berecz G; Pintér N; Diószeghy P; Virga A; Mechler F
Orv Hetil; 1988 Feb; 129(8):399-402. PubMed ID: 3279375
[No Abstract] [Full Text] [Related]
8. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
9. [Bromocriptine in the treatment of Parkinson's disease].
Sepcić J; Ledić P
Neurologija; 1982; 30(1-4):75-81. PubMed ID: 6765062
[No Abstract] [Full Text] [Related]
10. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
11. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
Rascol A; Montastruc JL; Guiraud-Chaumeil B; Clanet M
Rev Neurol (Paris); 1982; 138(5):401-8. PubMed ID: 7146724
[TBL] [Abstract][Full Text] [Related]
12. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
Stern GM; Lees AJ
Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
[TBL] [Abstract][Full Text] [Related]
13. Further experiences with low doses of bromocriptine in Parkinson's disease.
Fahn S; Côté LJ; Barrett RE; Snider SR
Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
[No Abstract] [Full Text] [Related]
14. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
[TBL] [Abstract][Full Text] [Related]
15. Low dose bromocriptine in Parkinson disease. Effects on the clinical picture and hypophyseal hormones.
Plascencia-Fuentes JM; Cabañas-García A; Corona-Vázquez T; Estañol-Vidal B; López-Mora M; Zárate-Treviño A
Arch Invest Med (Mex); 1986; 17(2):135-46. PubMed ID: 3592889
[No Abstract] [Full Text] [Related]
16. Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient.
Sandyk R
J Clin Psychopharmacol; 1987 Apr; 7(2):114-5. PubMed ID: 3584516
[No Abstract] [Full Text] [Related]
17. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
Lieberman AN; Kupersmith M; Neophytides A; Gopinathan G; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
Adv Biochem Psychopharmacol; 1980; 23():245-53. PubMed ID: 7395614
[No Abstract] [Full Text] [Related]
18. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
19. Clinical administration of parlodel in low doses.
Lipcsey A; Peres A
Adv Neurol; 1984; 40():557-61. PubMed ID: 6695636
[No Abstract] [Full Text] [Related]
20. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
Godwin-Austen RB
Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
